Work

Tissue and circulating biomarkers in advanced melanoma patients receiving dabrafenib and trametinib

Year: 2026

Type: article

Abstract: Tissue and circulating biomarkers in advanced

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.70697

Authors: Mario Mandalà, Marco Tucci, Maria Cristina Sini, Sara Baglivo, Sara Simi, Silvia Costabile, Elisabetta Gambale, Chiara Quitadamo, Patrizia Leone, Vito Racanelli, Maria Grazia Doro, Laura Frogheri, Ivana Persico, Naomi Viapiana, Daniela Massi, Giuseppe Palmieri, TWIN group and Italian Melanoma Intergroup (IMI)

Institutions: University of Perugia, Azienda Ospedaliera di Perugia, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, University of Bari Aldo Moro, National Research Council, University of Florence, University of Trento, Ospedale Santa Chiara, Novartis (Italy), New York University, University of Sassari

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W7208767207

FWCI:

Cites: 5

Cited by:

Related to: